Ewelina Kruszewska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ewelina Kruszewska has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Anna Moniuszko-Malinowska
Department of Infectious Diseases and Neuroinfection, Medical University of Bialystok, Żurawia 14, 15-540 Bialystok, Poland
14 shared publications Piotr Czupryna
Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Bialystok, Poland
9 shared publicationsAnna Moniuszko-Malinowska
Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Bialystok, Poland
5 shared publications- Piotr Czupryna
Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, 15-540 Bialystok, Poland
5 shared publications Sambor Grygorczuk
Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Żurawia 14, 15-540 Bialystok, Poland
5 shared publicationsSławomir Pancewicz
Department of Infectious Diseases and Neuroinfections, Medical University in Bialystok, Białystok, Podlaskie, Poland
5 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (12) , 5549
Evaluation of CXCL12 Diagnostic Performance in Tick-Borne Encephalitis and Other Central Nervous System Infections
CXCL12 is a chemokine acting via CXCR4 that plays a key role in inflammatory processes by regulating leukocyte migration and immune responses, making it an important focus of research in neuroinfections. In this study, the CXCL12 chemokine was evaluated as a potential diagnostic marker of different neuroinfections with particular emphasis on tick-borne encephalitis (TBE). A group of 214 patients with confirmed meningitis and/or encephalitis was included and divided according to etiology into TBE, aseptic meningitis, neuroborreliosis, and purulent meningitis. CXCL12 concentration and other inflammatory parameters were measured in cerebrospinal fluid (CSF). CXCL12 levels were compared with those of controls (N = 25) and analyzed statistically. In addition, serum was used to determine albumin concentrations. CXCL12 concentrations were significantly higher in patients with neuroinfections compared to controls and showed good diagnostic performance in the overall study group (AUC = 0.791), with a more moderate diagnostic performance observed in individual etiological groups, except in the purulent meningitis group, where the effect was not statistically significant, likely due to the small sample size. CXCL12 also demonstrated some utility in differentiating between specific etiologies; however, this effect was limited. Better diagnostic performance was observed when CXCL12 was combined with pleocytosis in a composite model differentiating between the TBE group and aseptic meningitis (AUC = 0.761). The presented results indicate the role of CXCL12 in neuroinflammation while simultaneously highlighting its potential in the development of novel diagnostic approaches for viral neuroinfections. Despite higher levels in TBE, its standalone diagnostic value is limited; however, it may enhance diagnostic accuracy when combined with other markers such as pleocytosis.
- 19 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (12) , 5549
Open AccessEvaluation of CXCL12 Diagnostic Performance in Tick-Borne Encephalitis and Other Central Nervous System Infections
CXCL12 is a chemokine acting via CXCR4 that plays a key role in inflammatory processes by regulating leukocyte migration and immune responses, making it an important focus of research in neuroinfections. In this study, the CXCL12 chemokine was evaluated as a potential diagnostic marker of different neuroinfections with particular emphasis on tick-borne encephalitis (TBE). A group of 214 patients with confirmed meningitis and/or encephalitis was included and divided according to etiology into TBE, aseptic meningitis, neuroborreliosis, and purulent meningitis. CXCL12 concentration and other inflammatory parameters were measured in cerebrospinal fluid (CSF). CXCL12 levels were compared with those of controls (N = 25) and analyzed statistically. In addition, serum was used to determine albumin concentrations. CXCL12 concentrations were significantly higher in patients with neuroinfections compared to controls and showed good diagnostic performance in the overall study group (AUC = 0.791), with a more moderate diagnostic performance observed in individual etiological groups, except in the purulent meningitis group, where the effect was not statistically significant, likely due to the small sample size. CXCL12 also demonstrated some utility in differentiating between specific etiologies; however, this effect was limited. Better diagnostic performance was observed when CXCL12 was combined with pleocytosis in a composite model differentiating between the TBE group and aseptic meningitis (AUC = 0.761). The presented results indicate the role of CXCL12 in neuroinflammation while simultaneously highlighting its potential in the development of novel diagnostic approaches for viral neuroinfections. Despite higher levels in TBE, its standalone diagnostic value is limited; however, it may enhance diagnostic accuracy when combined with other markers such as pleocytosis.
- Open Access
- 28 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Effectiveness of hydrogen peroxide fumigation using an automated fogging system for environmental management in educational institutions
The presence of microbial contamination on surfaces in early childhood education facilities poses a significant public health risk. Traditional cleaning methods often fail to fully eliminate pathogens, necessitating the development of more effective disinfection strategies. Hydrogen peroxide fumigation has emerged as a promising approach due to its broad-spectrum antimicrobial activity, environmental safety, and ability to penetrate biofilms, with potential implications for broader environmental management strategies. This study aimed to evaluate the effectiveness of a novel, fully automated fogging cabinet that generates hydrogen peroxide dry mist for disinfecting toys in educational settings. The most frequently detected bacteria before disinfection included Micrococcus luteus and Staphylococcus hominis , accounting for 30.3–40% and 22.8–32.2% of total bacterial contamination, respectively. The overall disinfection effectiveness was 97.8%, 97%, and 98.7% across the three tested facilities ( p < 0.001). Near-complete eradication (≥ 99%) was observed for Acinetobacter lwoffii , Pseudomonas luteola , and Staphylococcus haemolyticus . The findings corroborate previous research on the efficacy of hydrogen peroxide disinfection, including studies on public transportation and healthcare settings. The project, conducted with MEDILAB Sp. z o.o., resulted in the development of a portable, automated fogging cabinet for disinfecting toys. A pilot study was carried out in three educational institutions in Białystok, Poland, where 180 microbiological samples were collected from plastic toys before and after disinfection. The process used a hydrogen peroxide-based mist generated inside the cabinet over 30 min. Samples were incubated, and bacterial colonies were identified using MALDI-TOF mass spectrometry (VITEK MS). Statistical analysis confirmed the effectiveness of the disinfection method. This study demonstrates that the newly developed hydrogen peroxide-based fogging cabinet is an effective and reliable method for mitigating bacterial contamination on toys in early childhood education facilities. Its automated, contact-free application minimizes human error and ensures consistent disinfection, supporting the broader implementation of hydrogen peroxide fumigation as a standardized disinfection strategy in educational and other high-contact environments. Furthermore, the proposed automated fogging system represents an innovative approach by eliminating human error and ensuring uniform disinfectant distribution.
- 28 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessEffectiveness of hydrogen peroxide fumigation using an automated fogging system for environmental management in educational institutions
The presence of microbial contamination on surfaces in early childhood education facilities poses a significant public health risk. Traditional cleaning methods often fail to fully eliminate pathogens, necessitating the development of more effective disinfection strategies. Hydrogen peroxide fumigation has emerged as a promising approach due to its broad-spectrum antimicrobial activity, environmental safety, and ability to penetrate biofilms, with potential implications for broader environmental management strategies. This study aimed to evaluate the effectiveness of a novel, fully automated fogging cabinet that generates hydrogen peroxide dry mist for disinfecting toys in educational settings. The most frequently detected bacteria before disinfection included Micrococcus luteus and Staphylococcus hominis , accounting for 30.3–40% and 22.8–32.2% of total bacterial contamination, respectively. The overall disinfection effectiveness was 97.8%, 97%, and 98.7% across the three tested facilities ( p < 0.001). Near-complete eradication (≥ 99%) was observed for Acinetobacter lwoffii , Pseudomonas luteola , and Staphylococcus haemolyticus . The findings corroborate previous research on the efficacy of hydrogen peroxide disinfection, including studies on public transportation and healthcare settings. The project, conducted with MEDILAB Sp. z o.o., resulted in the development of a portable, automated fogging cabinet for disinfecting toys. A pilot study was carried out in three educational institutions in Białystok, Poland, where 180 microbiological samples were collected from plastic toys before and after disinfection. The process used a hydrogen peroxide-based mist generated inside the cabinet over 30 min. Samples were incubated, and bacterial colonies were identified using MALDI-TOF mass spectrometry (VITEK MS). Statistical analysis confirmed the effectiveness of the disinfection method. This study demonstrates that the newly developed hydrogen peroxide-based fogging cabinet is an effective and reliable method for mitigating bacterial contamination on toys in early childhood education facilities. Its automated, contact-free application minimizes human error and ensures consistent disinfection, supporting the broader implementation of hydrogen peroxide fumigation as a standardized disinfection strategy in educational and other high-contact environments. Furthermore, the proposed automated fogging system represents an innovative approach by eliminating human error and ensuring uniform disinfectant distribution.
- Open Access
- 21 March 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 198, 119219
Lipidomic insights into infectious meningitis: Pathogen-specific alterations and therapeutic implications
- 21 March 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 198, 119219
Open AccessLipidomic insights into infectious meningitis: Pathogen-specific alterations and therapeutic implications
- Open Access
- 11 February 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 196, 118995
The influence of Borrelia burgdorferi and Anaplasma phagocytophilum bacteria on phospholipid metabolism in the blood of patients
- 11 February 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 196, 118995
Open AccessThe influence of Borrelia burgdorferi and Anaplasma phagocytophilum bacteria on phospholipid metabolism in the blood of patients
- Open Access
- 27 December 2025
- Published by MDPI AG in Diagnostics
- Vol. 16 (1) , 95
Exploring the Role of Cerebrospinal Fluid and Serum Mid-Regional Pro-Adrenomedullin in Tick-Borne Encephalitis: A Pilot Study
Background: Adrenomedullin (ADM) is a multifunctional peptide with vasoregulatory, antimicrobial, and anti-inflammatory properties. Its stable fragment, mid-regional pro-adrenomedullin (MR-proADM), is a validated biomarker in sepsis and systemic infections, but its role in viral neuroinfections remains unexplored. Tick-borne encephalitis (TBE), caused by the tick-borne encephalitis virus (TBEV), is a major viral infection of the central nervous system (CNS) associated with long-term neurological sequelae. This study aimed to assess MR-proADM levels in cerebrospinal fluid (CSF) and serum of patients with TBE and to evaluate their diagnostic utility and pathophysiological significance. Methods: This retrospective observational study included 20 patients with confirmed TBE and 14 non-infectious neurological controls. MR-proADM concentrations were measured in paired CSF and serum samples using an ELISA assay. Statistical analyses included group comparisons (Mann–Whitney U test), correlation analyses (Spearman’s r), and receiver operating characteristic (ROC) curve evaluation. Results: Serum MR-proADM levels at baseline (SER1) were significantly lower in TBE patients compared with controls (p = 0.0197). The CSF/serum MR-proADM ratio differed significantly between groups (p = 0.0063) and showed the best diagnostic performance (AUC = 0.816, 95% CI 0.63–0.93; sensitivity 79%, specificity 80%). MR-proADM concentrations in CSF correlated with total CSF protein (r = 0.53), suggesting an association with blood–CSF barrier dysfunction. Strong reproducibility was observed for serum MR-proADM between sampling points (r = 0.83). Conclusions: MR-proADM levels in CSF and serum are altered in patients with TBE, indicating its potential as a biomarker of CNS infection and inflammation. The CSF/serum MR-proADM ratio may serve as a sensitive indicator of blood–CSF barrier involvement, while decreased serum levels may reflect impaired systemic neuroprotective response. These findings highlight a possible role of ADM in neuroimmune regulation during viral encephalitis and warrant validation in larger prospective studies.
- 27 December 2025
- Published by MDPI AG in Diagnostics
- Vol. 16 (1) , 95
Open AccessExploring the Role of Cerebrospinal Fluid and Serum Mid-Regional Pro-Adrenomedullin in Tick-Borne Encephalitis: A Pilot Study
Background: Adrenomedullin (ADM) is a multifunctional peptide with vasoregulatory, antimicrobial, and anti-inflammatory properties. Its stable fragment, mid-regional pro-adrenomedullin (MR-proADM), is a validated biomarker in sepsis and systemic infections, but its role in viral neuroinfections remains unexplored. Tick-borne encephalitis (TBE), caused by the tick-borne encephalitis virus (TBEV), is a major viral infection of the central nervous system (CNS) associated with long-term neurological sequelae. This study aimed to assess MR-proADM levels in cerebrospinal fluid (CSF) and serum of patients with TBE and to evaluate their diagnostic utility and pathophysiological significance. Methods: This retrospective observational study included 20 patients with confirmed TBE and 14 non-infectious neurological controls. MR-proADM concentrations were measured in paired CSF and serum samples using an ELISA assay. Statistical analyses included group comparisons (Mann–Whitney U test), correlation analyses (Spearman’s r), and receiver operating characteristic (ROC) curve evaluation. Results: Serum MR-proADM levels at baseline (SER1) were significantly lower in TBE patients compared with controls (p = 0.0197). The CSF/serum MR-proADM ratio differed significantly between groups (p = 0.0063) and showed the best diagnostic performance (AUC = 0.816, 95% CI 0.63–0.93; sensitivity 79%, specificity 80%). MR-proADM concentrations in CSF correlated with total CSF protein (r = 0.53), suggesting an association with blood–CSF barrier dysfunction. Strong reproducibility was observed for serum MR-proADM between sampling points (r = 0.83). Conclusions: MR-proADM levels in CSF and serum are altered in patients with TBE, indicating its potential as a biomarker of CNS infection and inflammation. The CSF/serum MR-proADM ratio may serve as a sensitive indicator of blood–CSF barrier involvement, while decreased serum levels may reflect impaired systemic neuroprotective response. These findings highlight a possible role of ADM in neuroimmune regulation during viral encephalitis and warrant validation in larger prospective studies.
- Open Access
- 6 February 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 200, 107337
Proteomic changes in serum of patients with Erythema migrans, Anaplasma phagocytophilum infection and co-infection
- 6 February 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 200, 107337
Open AccessProteomic changes in serum of patients with Erythema migrans, Anaplasma phagocytophilum infection and co-infection
- Open Access
- 2 February 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 337
Cerebrospinal Fluid Calcium Balance in Tick-Borne Encephalitis: A Preliminary Study and Future Research Directions
Introduction: Calcium homeostasis is essential for neurophysiological functions, with dysregulation implicated in neurodegenerative diseases. Recent studies suggest that specific viral brain infections, such as tick-borne encephalitis, can initiate neuronal loss and subsequent neurodegenerative changes. This study examines alterations in calcium levels within the cerebrospinal fluid (CSF) of patients with tick-borne encephalitis (TBE). Objectives: To evaluate the concentration of calcium in the CSF of TBE patients and assess its potential as a diagnostic marker for disease severity. Materials and Methods: CSF samples were collected from 42 subjects (11 controls, 20 with TBE, 11 with other forms of meningitis). Calcium levels were measured using the Alinity c analyzer. Statistical analyses included the Shapiro–Wilk test, Mann–Whitney U test, and ROC curve analysis. Results: Calcium levels were significantly lower in TBE patients compared to controls (mean 0.85 mmol/L vs. 0.98 mmol/L). Lower calcium levels were associated with milder cases of TBE. ROC analysis (AUC 0.802, p-value 0.0053) supports the diagnostic utility of calcium concentration in differentiating TBE severity. The optimal cut-off value for calcium was >3.09 mg/dL, with a sensitivity of 84.62% and specificity of 71.43%. These findings further emphasize the potential of calcium as a diagnostic marker for TBEV. Conclusions: The observed differences in CSF calcium levels between mild and severe TBE cases highlight its potential as a diagnostic marker. Further research is warranted to elucidate calcium’s role in TBE, aiming to improve clinical management and reduce complications. We emphasize that this study is one of the first to propose calcium levels as a potential biomarker for assessing the severity of tick-borne encephalitis, offering a new perspective in the diagnostic approach to this infection.
- 2 February 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 337
Open AccessCerebrospinal Fluid Calcium Balance in Tick-Borne Encephalitis: A Preliminary Study and Future Research Directions
Introduction: Calcium homeostasis is essential for neurophysiological functions, with dysregulation implicated in neurodegenerative diseases. Recent studies suggest that specific viral brain infections, such as tick-borne encephalitis, can initiate neuronal loss and subsequent neurodegenerative changes. This study examines alterations in calcium levels within the cerebrospinal fluid (CSF) of patients with tick-borne encephalitis (TBE). Objectives: To evaluate the concentration of calcium in the CSF of TBE patients and assess its potential as a diagnostic marker for disease severity. Materials and Methods: CSF samples were collected from 42 subjects (11 controls, 20 with TBE, 11 with other forms of meningitis). Calcium levels were measured using the Alinity c analyzer. Statistical analyses included the Shapiro–Wilk test, Mann–Whitney U test, and ROC curve analysis. Results: Calcium levels were significantly lower in TBE patients compared to controls (mean 0.85 mmol/L vs. 0.98 mmol/L). Lower calcium levels were associated with milder cases of TBE. ROC analysis (AUC 0.802, p-value 0.0053) supports the diagnostic utility of calcium concentration in differentiating TBE severity. The optimal cut-off value for calcium was >3.09 mg/dL, with a sensitivity of 84.62% and specificity of 71.43%. These findings further emphasize the potential of calcium as a diagnostic marker for TBEV. Conclusions: The observed differences in CSF calcium levels between mild and severe TBE cases highlight its potential as a diagnostic marker. Further research is warranted to elucidate calcium’s role in TBE, aiming to improve clinical management and reduce complications. We emphasize that this study is one of the first to propose calcium levels as a potential biomarker for assessing the severity of tick-borne encephalitis, offering a new perspective in the diagnostic approach to this infection.
- Open Access
- 28 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-15
Clinical usefulness of the serum levels of neuroinflammatory and lung fibrosis biomarkers in the assessment of cognitive dysfunction in post-COVID19 patients
A growing body of evidence indicates there is an increasing incidence of cognitive dysfunction in patients after coronavirus disease 2019 (COVID-19) infection. However, still lack diagnostic tools, which allow us to predict prognosis in such cases and improve the stratification of the disease. This study aims to evaluate the usefulness of the biomarkers that could allow to predict the severity and progression of COVID-19 in patients with post-COVID syndrome and cognitive problems. Data regarding clinical history, pre-existing conditions, chest CT scan, and therapy (remdesivir, steroids) were acquired. A total of 44 patients with hospitalized COVID-19, and healthy controls were enrolled in the investigation, and serum blood was obtained. After 6 months of observations, patients with COVID-19 were divided into two groups: first - without post-COVID syndrome and memory complaints, and second - with post-COVID and cognitive problems. Measurements of YKL-40 and MR-pro-ADM were taken in the serum with enzyme immunoassay kits at the time of admission (visit 1) and 6 months after discharge from the hospital (visit 2). Significantly higher concentrations of YKL-40 were found in patients with COVID-19 as compared to healthy individuals (p = 0.016). Moreover, YKL-40 ratio allowed to differentiate patients with and without post-COVID syndrome (median: 0.94 vs. 1.55, p = 0.004). Additionally, COVID-19 patients with dyspnea presented significantly elevated levels of MR-pro-ADM as compared to the group of COVID-19 survivors without dyspnea (p = 0.015). In the group of patients without post-COVID syndrome, the concentrations of YKL-40 and MR-pro-ADM decreased after treatment as compared to levels before therapy (77 vs. 36 ng/ml and 607 vs. 456 pmol/L). However, in patients with post-COVID syndrome and cognitive problems, the levels of both markers did not alter 6 months after hospital discharge in comparison to basal levels. Furthermore, after dexamethasone treatment the YKL-40 concentrations declined significantly (p = 0.003) in patients with COVID-19. This study demonstrated the predictive usefulness of YKL-40 as an indicator of successful treatment in patients with COVID-19 infection allowing risk stratification of hospitalized patients. It seems that indicators of neuroinflammation might have the potential to track development of cognitive complaints, however, it requires further investigations.
- 28 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-15
Open AccessClinical usefulness of the serum levels of neuroinflammatory and lung fibrosis biomarkers in the assessment of cognitive dysfunction in post-COVID19 patients
A growing body of evidence indicates there is an increasing incidence of cognitive dysfunction in patients after coronavirus disease 2019 (COVID-19) infection. However, still lack diagnostic tools, which allow us to predict prognosis in such cases and improve the stratification of the disease. This study aims to evaluate the usefulness of the biomarkers that could allow to predict the severity and progression of COVID-19 in patients with post-COVID syndrome and cognitive problems. Data regarding clinical history, pre-existing conditions, chest CT scan, and therapy (remdesivir, steroids) were acquired. A total of 44 patients with hospitalized COVID-19, and healthy controls were enrolled in the investigation, and serum blood was obtained. After 6 months of observations, patients with COVID-19 were divided into two groups: first - without post-COVID syndrome and memory complaints, and second - with post-COVID and cognitive problems. Measurements of YKL-40 and MR-pro-ADM were taken in the serum with enzyme immunoassay kits at the time of admission (visit 1) and 6 months after discharge from the hospital (visit 2). Significantly higher concentrations of YKL-40 were found in patients with COVID-19 as compared to healthy individuals (p = 0.016). Moreover, YKL-40 ratio allowed to differentiate patients with and without post-COVID syndrome (median: 0.94 vs. 1.55, p = 0.004). Additionally, COVID-19 patients with dyspnea presented significantly elevated levels of MR-pro-ADM as compared to the group of COVID-19 survivors without dyspnea (p = 0.015). In the group of patients without post-COVID syndrome, the concentrations of YKL-40 and MR-pro-ADM decreased after treatment as compared to levels before therapy (77 vs. 36 ng/ml and 607 vs. 456 pmol/L). However, in patients with post-COVID syndrome and cognitive problems, the levels of both markers did not alter 6 months after hospital discharge in comparison to basal levels. Furthermore, after dexamethasone treatment the YKL-40 concentrations declined significantly (p = 0.003) in patients with COVID-19. This study demonstrated the predictive usefulness of YKL-40 as an indicator of successful treatment in patients with COVID-19 infection allowing risk stratification of hospitalized patients. It seems that indicators of neuroinflammation might have the potential to track development of cognitive complaints, however, it requires further investigations.
- Open Access
- 11 April 2024
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 30, e944052-e944052-12
Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Consequences and Anti-Inflammatory Treatment
Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Consequences and Anti-Inflammatory Treatment - Article abstract #944052
- 11 April 2024
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 30, e944052-e944052-12
Open AccessDifferential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Consequences and Anti-Inflammatory Treatment
Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Consequences and Anti-Inflammatory Treatment - Article abstract #944052